HIMS & HERS HEALTH INC (HIMS) Forecast, Price Target & Analyst Ratings

NYSE:HIMSUS4330001060

Current stock price

19.43 USD
-0.32 (-1.62%)
At close:
19.15 USD
-0.28 (-1.44%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HIMS & HERS HEALTH INC (HIMS).

Forecast Snapshot

Consensus Price Target

Price Target
$25.48
+ 31.15% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.03
Revenue Estimate
628.79M

ChartMill Buy Consensus

Rating
70.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$25.48
Upside
+ 31.15%
From current price of $19.43 to mean target of $25.48, Based on 22 analyst forecasts
Low
$16.16
Median
$24.48
High
$36.75

Price Target Revisions

1 Month
-15.07%
3 Months
-45.07%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for HIMS. The average price target is 25.48 USD. This implies a price increase of 31.15% is expected in the next year compared to the current price of 19.43.
The average price target has been revised downward by 45.07% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

HIMS Current Analyst RatingHIMS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

HIMS Historical Analyst RatingsHIMS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
70.00%
HIMS was analyzed by 22 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about HIMS.
In the last month the buy percentage rose by 16 points. So the trust of analysts is improving.
HIMS was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-27TD CowenMaintains Hold -> Hold
2026-03-16Leerink PartnersMaintains Market Perform -> Market Perform
2026-03-11BarclaysMaintains Overweight -> Overweight
2026-03-10Deutsche BankMaintains Hold -> Hold
2026-03-10B of A SecuritiesUpgrade Underperform -> Neutral
2026-03-10CitigroupUpgrade Sell -> Neutral
2026-03-09NeedhamUpgrade Hold -> Buy
2026-02-25BarclaysMaintains Overweight -> Overweight
2026-02-25Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2026-02-24Leerink PartnersMaintains Market Perform -> Market Perform
2026-02-24TD CowenMaintains Hold -> Hold
2026-02-24BTIGDowngrade Buy -> Neutral
2026-02-24Evercore ISI GroupMaintains In-Line -> In-Line
2026-02-24Truist SecuritiesReiterate Hold -> Hold
2026-02-24CitigroupMaintains Sell -> Sell
2026-02-09TD CowenMaintains Hold -> Hold
2026-02-09B of A SecuritiesMaintains Underperform -> Underperform
2026-02-09CitigroupMaintains Sell -> Sell
2026-02-02BTIGMaintains Buy -> Buy
2026-01-12Evercore ISI GroupInitiate In-Line
2025-12-09BarclaysInitiate Overweight
2025-11-04BTIGReiterate Buy -> Buy
2025-11-04B of A SecuritiesMaintains Underperform -> Underperform
2025-10-21KeybancInitiate Sector Weight
2025-09-12Canaccord GenuityMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.03
Revenue Estimate
628.79M
Revenue Q2Q
7.30%
EPS Q2Q
-83.77%
Number of Analysts
15

Next Earnings Revisions

Revenue (1 Month)
-0.53%
Revenue (3 Months)
-5.81%
EPS (1 Month)
-45.14%
EPS (3 Months)
-79.18%

Next Earnings Summary

HIMS is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.03 USD and the consensus revenue estimate is 628.79M USD.
The next earnings revenue estimate has been revised downward by 5.81% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
HIMS revenue by date.HIMS revenue by date.
872M
65.49%
1.477B
69.33%
2.348B
59.00%
2.817B
19.99%
3.358B
19.20%
3.903B
16.23%
4.107B
5.23%
4.722B
14.97%
5.818B
23.21%
6.809B
17.03%
5.048B
-25.86%
EBITDA
YoY % growth
HIMS ebitda by date.HIMS ebitda by date.
-16.493M
72.00%
85.092M
615.93%
176.19M
107.06%
335.48M
90.41%
428.37M
27.69%
525.79M
22.74%
650.32M
23.68%
803.76M
23.59%
865.06M
7.63%
1.036B
19.76%
1.163B
12.26%
EBIT
YoY % growth
HIMS ebit by date.HIMS ebit by date.
-26.008M
60.82%
68.004M
361.47%
121.688M
78.94%
160.61M
31.99%
203.41M
26.65%
283.45M
39.35%
420.23M
48.26%
629.34M
49.76%
716.18M
13.80%
834.27M
16.49%
913.76M
9.53%
Operating Margin
HIMS operating margin by date.HIMS operating margin by date.
-2.98%4.61%5.18%5.70%6.06%7.26%10.23%13.33%12.31%12.25%18.10%
EPS
YoY % growth
HIMS eps by date.HIMS eps by date.
-0.11
65.63%
0.54
590.91%
0.51
-5.56%
0.58
14.00%
0.64
9.94%
1.21
89.66%
1.90
56.49%
3.97
109.14%
5.10
28.53%
6.55
28.40%
N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
0.03
-83.77%
0.11
-37.82%
0.17
179.74%
0.20
149.21%
0.09
182.84%
0.14
35.08%
0.24
45.85%
0.31
55.19%
0.19
111.11%
0.23
64.29%
0.40
62.50%
0.41
31.87%
Revenue
Q2Q % growth
628.79M
7.30%
660.44M
21.22%
736.19M
22.91%
785.49M
27.14%
773.04M
22.94%
799.44M
21.05%
849.36M
15.37%
879.67M
11.99%
932.38M
20.61%
973.69M
21.80%
1.003B
18.09%
1.031B
17.20%
EBITDA
Q2Q % growth
50.198M
-24.17%
74.009M
43.16%
99.506M
82.29%
109.1M
62.50%
73.993M
47.40%
96.639M
30.58%
112.41M
12.97%
117.17M
7.40%
85.782M
15.93%
93.942M
-2.79%
126.07M
12.15%
129.03M
10.12%
EBIT
Q2Q % growth
11.499M
-80.15%
32.021M
-2.83%
55.752M
206.73%
61.705M
388.29%
34.425M
199.37%
53.448M
66.92%
72.93M
30.81%
77.928M
26.29%
31.62M
-8.15%
39.678M
-25.76%
71.808M
-1.54%
74.868M
-3.93%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HIMS Yearly Revenue VS EstimatesHIMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
HIMS Yearly EPS VS EstimatesHIMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
33.46%
EPS Next 5 Year
50.73%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
17.66%
Revenue Next 5 Year
14.53%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
66.22%
EBIT Next 5 Year
47.66%

HIMS & HERS HEALTH INC / HIMS Forecast FAQ

What is the price target for HIMS stock?

22 analysts have analysed HIMS and the average price target is 25.48 USD. This implies a price increase of 31.15% is expected in the next year compared to the current price of 19.43.

When does HIMS & HERS HEALTH INC (HIMS) report earnings?

HIMS & HERS HEALTH INC (HIMS) will report earnings on 2026-05-04.

What are the consensus estimates for HIMS & HERS HEALTH INC (HIMS) next earnings?

The consensus EPS estimate for the next earnings of HIMS & HERS HEALTH INC (HIMS) is 0.03 USD and the consensus revenue estimate is 628.79M USD.

What is the expected long term growth rate for HIMS stock?

The expected long term growth rate for HIMS & HERS HEALTH INC (HIMS) is 17.66%.